Drug Database
TH
thrombin (ThrombiRAAS)
✓ ApprovedShanghai RAAS Blood Products Co., Ltd. · F2 · Cell-based Therapies
What is thrombin?
thrombin is a cell-based therapies developed by Shanghai RAAS Blood Products Co., Ltd.. It is approved for therapeutic indications via oral (po).
Drug Profile
| Brand Names | ThrombiRAAS |
| Company | Shanghai RAAS Blood Products Co., Ltd. |
| Drug Class | Cell-based Therapies |
| Molecular Target | F2 |
| Route | Oral (PO) |
| Status | Approved |
Mechanism of Action
Molecular Targets
thrombin acts on 1 molecular target:
| F2 | coagulation factor II, thrombin (THPH1, PT) |
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.
Therapeutic Indications
thrombin is developed for 2 unique indications across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Vascular disorders | Extravasation blood | ✓ Approved |
| Vascular disorders | Haemorrhage | ✓ Approved |
Related Research Articles
Unable to load articles right now.